Explore
Validate
Learn
Immunocytochemistry
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [11]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA002465 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA002465, RRID:AB_1079179
- Product name
- Anti-KRT19
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human KRT19, Gene description: keratin 19, Alternative Gene Names: CK19, K19, K1CS, MGC15366, Validated applications: IHC, ICC, Uniprot ID: P08727, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references EZH2 inhibitors promote β-like cell regeneration in young and adult type 1 diabetes donors
Augmented Global Protein Acetylation Diminishes Cell Growth and Migration of Cholangiocarcinoma Cells
Pharmacological inhibition of human EZH2 can influence a regenerative β-like cell capacity with in vitro insulin release in pancreatic ductal cells
Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation.
Circulating Tumour Cells Indicate the Presence of Residual Disease Post-Castration in Prostate Cancer Patient-Derived Xenograft Models
Diversity of Epithelial-Mesenchymal Phenotypes in Circulating Tumour Cells from Prostate Cancer Patient-Derived Xenograft Models
Chromomycin A3 suppresses cholangiocarcinoma growth by induction of S phase cell cycle arrest and suppression of Sp1‑related anti‑apoptotic proteins
Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model
Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis
Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells
Antigen Masking During Fixation and Embedding, Dissected
Al-Hasani K, Marikar S, Kaipananickal H, Maxwell S, Okabe J, Khurana I, Karagiannis T, Liang J, Mariana L, Loudovaris T, Kay T, El-Osta A
Signal Transduction and Targeted Therapy 2024;9(1)
Signal Transduction and Targeted Therapy 2024;9(1)
Augmented Global Protein Acetylation Diminishes Cell Growth and Migration of Cholangiocarcinoma Cells
Saisomboon S, Kariya R, Mahalapbutr P, Insawang T, Sawanyawisuth K, Cha’on U, Rungrotmongkol T, Wongkham S, Jitrapakdee S, Okada S, Vaeteewoottacharn K
International Journal of Molecular Sciences 2024;25(18):10170
International Journal of Molecular Sciences 2024;25(18):10170
Pharmacological inhibition of human EZH2 can influence a regenerative β-like cell capacity with in vitro insulin release in pancreatic ductal cells
Naina Marikar S, Al-Hasani K, Khurana I, Kaipananickal H, Okabe J, Maxwell S, El-Osta A
Clinical Epigenetics 2023;15(1)
Clinical Epigenetics 2023;15(1)
Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation.
Serra-Camprubí Q, Verdaguer H, Oliveros W, Lupión-Garcia N, Llop-Guevara A, Molina C, Vila-Casadesús M, Turpin A, Neuzillet C, Frigola J, Querol J, Yáñez-Bartolomé M, Castet F, Fabregat-Franco C, Escudero-Iriarte C, Escorihuela M, Arenas EJ, Bernadó-Morales C, Haro N, Giles FJ, Pozo ÓJ, Miquel JM, Nuciforo PG, Vivancos A, Melé M, Serra V, Arribas J, Tabernero J, Peiró S, Macarulla T, Tian TV
Clinical cancer research : an official journal of the American Association for Cancer Research 2023 Jan 17;29(2):432-445
Clinical cancer research : an official journal of the American Association for Cancer Research 2023 Jan 17;29(2):432-445
Circulating Tumour Cells Indicate the Presence of Residual Disease Post-Castration in Prostate Cancer Patient-Derived Xenograft Models
Hassan S, Blick T, Wood J, Thompson E, Williams E
Frontiers in Cell and Developmental Biology 2022;10
Frontiers in Cell and Developmental Biology 2022;10
Diversity of Epithelial-Mesenchymal Phenotypes in Circulating Tumour Cells from Prostate Cancer Patient-Derived Xenograft Models
Hassan S, Blick T, Thompson E, Williams E
Cancers 2021;13(11):2750
Cancers 2021;13(11):2750
Chromomycin A3 suppresses cholangiocarcinoma growth by induction of S phase cell cycle arrest and suppression of Sp1‑related anti‑apoptotic proteins
Saranaruk P, Kariya R, Sittithumcharee G, Boueroy P, Boonmars T, Sawanyawisuth K, Wongkham C, Wongkham S, Okada S, Vaeteewoottacharn K
International Journal of Molecular Medicine 2020
International Journal of Molecular Medicine 2020
Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model
Vaeteewoottacharn K, Pairojkul C, Kariya R, Muisuk K, Imtawil K, Chamgramol Y, Bhudhisawasdi V, Khuntikeo N, Pugkhem A, Saeseow O, Silsirivanit A, Wongkham C, Wongkham S, Okada S
Cells 2019;8(5):496
Cells 2019;8(5):496
Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis
Vaeteewoottacharn K, Kariya R, Pothipan P, Fujikawa S, Pairojkul C, Waraasawapati S, Kuwahara K, Wongkham C, Wongkham S, Okada S
Translational Oncology 2019;12(2):217-225
Translational Oncology 2019;12(2):217-225
Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells
Saentaweesuk W, Araki N, Vaeteewoottacharn K, Silsirivanit A, Seubwai W, Talabnin C, Muisuk K, Sripa B, Wongkham S, Okada S, Wongkham C
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018;26(4):605-616
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018;26(4):605-616
Antigen Masking During Fixation and Embedding, Dissected
Scalia C, Boi G, Bolognesi M, Riva L, Manzoni M, DeSmedt L, Bosisio F, Ronchi S, Leone B, Cattoretti G
Journal of Histochemistry & Cytochemistry 2016;65(1):5-20
Journal of Histochemistry & Cytochemistry 2016;65(1):5-20
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human urinary bladder and lymph node tissues using HPA002465 antibody. Corresponding KRT19 RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
